• Users Online: 176
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Contacts Login 

    Article Cited by others

ORIGINAL ARTICLE

Topoisomerase I inhibitor suppress tumor growth in chemoresistant ovarian cancer-initiating cells

Wang Yu-Chi, Chang Cheng-Chang, Chiang Kai-Jo, Chao Tai-Kuang, Wu Chia-Chun, Chang Ping-Ying, Wu Chang-Chieh, Lai Hung-Cheng

Year : 2014| Volume: 34| Issue : 2 | Page no: 72-76

   This article has been cited by
 
1 Molecular mechanisms of drug resistance in ovarian cancer
Leyla Norouzi-Barough,Mohammad Reza Sarookhani,Mohammadreza Sharifi,Sahar Moghbelinejad,Saranaz Jangjoo,Rasoul Salehi
Journal of Cellular Physiology. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 A multicenter, open-label, expanded phase 2 study to evaluate the safety and efficacy of etirinotecan pegol, a polymer conjugate of irinotecan, in women with recurrent platinum-resistant or refractory ovarian cancer
G. Rustin,I. Vergote,J.P. Micha,L.R. Duska,N. Reed,J. Bendell,D. Spitz,G. Dark,U. Hoch,M. Tagliaferri,A.L. Hannah,A.A. Garcia
Gynecologic Oncology. 2017;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article